Hashtag messages don’t often carry deep meanings or life missions, but Nim Shah’s Twitter profile – yes, there’s at least one Medtecher who tweets – pretty much says it all:
#devicesforlife.
Shah latched himself onto Medtech 20 years ago, joining the prolific team of Alex Brown that produced many who moved Medtech over the next two decades.
Shah’s longest stint was at Domain Associates. But now he’s taken his talents to Fractyl Laboratories, one of the more interesting start-ups in Medtech.
In this podcast, Shah recounts the trail that led him to Fractyl, shares thoughts on JP Morgan, New England weather, and why Medtech and Biotech took such divergent paths.
Nimesh Shah
Chief Business Officer
Fractyl Laboratories
Nimesh Shah is Chief Business Officer of Fractyl. Nimesh brings with him nearly 20 years of venture capital and Wall Street experience specializing in early-stage or growth oriented medical device companies. Prior to joining Fractyl, Nimesh was a partner of Domain Associates, a leading health care venture capital firm, leading that firm’s efforts in medical devices. Previously, Nimesh served in various roles at venture firm Cutlass Capital and investment bank Alex. Brown (now Deutsche Bank). Nimesh received his B.S. in Biomedical Engineering from the Johns Hopkins University.
